MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202527123989 A) filed by Shanghai Henlius Biotech, Inc.; and Shanghai Henlius Biologics Co. , Ltd. on December 09, 2025, for Anti-Epidermal Growth Factor Receptor (egfr) Antibody-Drug Conjugate And Use Thereof.
Inventors include Shan, Yongqiang; Song, Hongbin; Song, Ge; Jiang, Jiahao; and Zhang, Wentao.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: An antibody-drug conjugate (ADC) and the use thereof. Specifically, the present invention relates to a novel anti-epidermal growth factor receptor (EGFR) antibody- drug conjugate, and a method of using same and the use thereof in the treatment of E...